Metraipolis › archive › dc_9513fc8b8a99

Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses — Europe PMC PMID:41562319

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41562319
DOI
10.1111/1348-0421.70039
License (as archived)
solo-consultazione
Archived
2026-11-06T15:58:21.917Z
SHA-256 of the archived text
d449b61e701cf4dd45f5ca80264a97983f6b48442e0e53b6b8d7f4a1fe255fb1
Stable URL of this page
https://metraipolis.com/documento/dc_9513fc8b8a99

How to cite

Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses — Europe PMC PMID:41562319 — Europe PMC (en), https://europepmc.org/article/MED/41562319 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9513fc8b8a99 (Metraipolis archive dc_9513fc8b8a99, sha256 d449b61e701cf4dd45f5ca80264a97983f6b48442e0e53b6b8d7f4a1fe255fb1)
BibTeX
@misc{dc9513fc8b8a99,
  title = {Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses — Europe PMC PMID:41562319},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562319},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9513fc8b8a99; sha256 d449b61e701cf4dd45f5ca80264a97983f6b48442e0e53b6b8d7f4a1fe255fb1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562319. Agents can read the archived copy with the MCP tool read_document.